ABUS logo

Arbutus Biopharma (ABUS) Short Term Debt

Annual Short Term Debt

$425.00 K
+$53.00 K+14.25%

December 31, 2023


Summary


Performance

ABUS Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABUSbalance sheetmetrics:

Quarterly Short Term Debt

$468.00 K
+$15.00 K+3.31%

September 30, 2024


Summary


Performance

ABUS Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABUSbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

ABUS Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.3%-6.8%
3 y3 years+9.0%+25.8%
5 y5 years+100.0%+25.8%

ABUS Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+14.3%-6.8%+30.0%
5 y5-yearat high+25.0%-6.8%+37.6%
alltimeall time-45.2%-100.0%-21.9%-100.0%

Arbutus Biopharma Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$468.00 K(+3.3%)
Jun 2024
-
$453.00 K(-9.8%)
Mar 2024
-
$502.00 K(+18.1%)
Dec 2023
$425.00 K(+14.2%)
$425.00 K(+3.2%)
Sep 2023
-
$412.00 K(+3.8%)
Jun 2023
-
$397.00 K(-11.0%)
Mar 2023
-
$446.00 K(+19.9%)
Dec 2022
$372.00 K(-2.9%)
$372.00 K(+3.3%)
Sep 2022
-
$360.00 K(-4.5%)
Jun 2022
-
$377.00 K(-14.1%)
Mar 2022
-
$439.00 K(+14.6%)
Dec 2021
$383.00 K(-1.8%)
$383.00 K(-0.8%)
Sep 2021
-
$386.00 K(+8.1%)
Jun 2021
-
$357.00 K(-17.4%)
Mar 2021
-
$432.00 K(+10.8%)
Dec 2020
$390.00 K(+14.7%)
$390.00 K(+3.2%)
Sep 2020
-
$378.00 K(+3.8%)
Jun 2020
-
$364.00 K(-10.8%)
Mar 2020
-
$408.00 K(+20.0%)
DateAnnualQuarterly
Dec 2019
$340.00 K(>+9900.0%)
$340.00 K(+3.3%)
Sep 2019
-
$329.00 K(-12.5%)
Jun 2019
-
$376.00 K(-37.2%)
Mar 2019
-
$599.00 K(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2008
-
$9200.00(-70.4%)
Jun 2008
-
$31.10 K(-39.8%)
Mar 2008
-
$51.70 K(-32.3%)
Dec 2007
$76.40 K(-8.1%)
$76.40 K(-25.6%)
Sep 2007
-
$102.70 K(+17.2%)
Jun 2007
-
$87.60 K
Dec 2006
$83.10 K(+67.5%)
-
Dec 2005
$49.60 K(-93.6%)
-
Dec 2004
$775.90 K(+86.3%)
-
Dec 2003
$416.40 K(+252.9%)
-
Dec 2001
$118.00 K(+116.1%)
-
Dec 2000
$54.60 K(+59.2%)
-
Dec 1999
$34.30 K(>+9900.0%)
-
Dec 1998
$0.00
-

FAQ

  • What is Arbutus Biopharma annual short term debt?
  • What is the all time high annual short term debt for Arbutus Biopharma?
  • What is Arbutus Biopharma annual short term debt year-on-year change?
  • What is Arbutus Biopharma quarterly short term debt?
  • What is the all time high quarterly short term debt for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly short term debt year-on-year change?

What is Arbutus Biopharma annual short term debt?

The current annual short term debt of ABUS is $425.00 K

What is the all time high annual short term debt for Arbutus Biopharma?

Arbutus Biopharma all-time high annual short term debt is $775.90 K

What is Arbutus Biopharma annual short term debt year-on-year change?

Over the past year, ABUS annual short term debt has changed by +$53.00 K (+14.25%)

What is Arbutus Biopharma quarterly short term debt?

The current quarterly short term debt of ABUS is $468.00 K

What is the all time high quarterly short term debt for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly short term debt is $599.00 K

What is Arbutus Biopharma quarterly short term debt year-on-year change?

Over the past year, ABUS quarterly short term debt has changed by -$34.00 K (-6.77%)